Compounds > 15-(4-iodophenyl)-3,3-dimethylpentadecanoic acid
Page last updated: 2024-12-07
15-(4-iodophenyl)-3,3-dimethylpentadecanoic acid
Description
15-(4-iodophenyl)-3,3-dimethylpentadecanoic acid is a synthetic molecule with a long alkyl chain and an iodophenyl group attached. It's not a well-known compound and there's little to no published information about its specific properties or biological activity.
However, its structural features suggest it might be of interest for research in several areas:
**1. Potential for Development as a Probe or Drug:**
* **Long Alkyl Chain:** This feature could make it suitable for interacting with lipid membranes, potentially targeting cellular processes related to membrane function or transport.
* **Iodophenyl Group:** This group is often incorporated into molecules for several reasons:
* **Radiolabeling:** Iodine-125 is a radioactive isotope used in various research applications, such as imaging studies and protein labeling.
* **Structural Modification:** The iodine atom can influence the molecule's physical properties and its interactions with biological targets.
**2. Chemical Synthesis and Modification:**
* **Building Block:** The presence of the iodophenyl group makes it a potential starting material for synthesizing more complex molecules with potential biological activity. The long alkyl chain could be used for further modifications, such as introducing different functional groups or attaching other molecules.
* **Studying Organic Reactions:** The molecule itself might be used as a model substrate to study the reactions of iodoarenes or long-chain carboxylic acids.
**3. Material Science:**
* **Self-Assembly:** The combination of a hydrophobic alkyl chain and a hydrophilic iodophenyl group might lead to self-assembly properties, potentially for applications in nanotechnology or material science.
**Importance for Research:**
Without more specific information on its properties and biological activity, it's difficult to definitively state its importance for research. However, its structural features suggest it could be a valuable tool or starting point for research in various fields. Further research is needed to investigate its potential applications.
**To learn more, it would be helpful to know:**
* What specific research areas are you interested in?
* What are the desired properties or activities for this molecule?
* Has this molecule been synthesized or characterized?
With more context, we can provide a more specific and accurate answer.
15-(4-iodophenyl)-3,3-dimethylpentadecanoic acid: labeled with 123I for myocardial imaging; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 128573 |
MeSH ID | M0141407 |
Synonyms (8)
Synonym |
dmipp |
MOLI000834 |
104426-56-4 |
15-(4-iodophenyl)-3,3-dimethylpentadecanoic acid |
benzenepentadecanoic acid, 4-(iodo-123i)-beta,beta-dimethyl- |
15-(4-(123i)iodanylphenyl)-3,3-dimethylpentadecanoic acid |
15-[4-(~123~i)iodophenyl]-3,3-dimethylpentadecanoic acid |
DTXSID30908969 |
Research
Studies (13)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 5 (38.46) | 18.7374 |
1990's | 8 (61.54) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.84
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.84 (24.57) | Research Supply Index | 2.71 (2.92) | Research Growth Index | 4.55 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (7.14%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (92.86%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |